Transient treatment of diabetic mice with two cytokines induces acinar-to-beta-cell conversion to an extent sufficient to durably restore normoglycemia.
References
Baeyens, L. et al. Nat. Biotechnol. 32, 76–83 (2014).
Pan, F.C. et al. Development 140, 751–764 (2013).
Thorel, F. et al. Nature 464, 1149–1154 (2010).
Bramswig, N.C. et al. J. Clin. Invest. 123, 1275–1284 (2013).
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D.A. Nature 455, 627–632 (2008).
Lee, J. et al. Cell 151, 547–558 (2012).
Dor, Y., Brown, J., Martinez, O.I. & Melton, D.A. Nature 429, 41–46 (2004).
Gu, G., Dubauskaite, J. & Melton, D.A. Development 129, 2447–2457 (2002).
Miyatsuka, T. et al. Genes Dev. 20, 1435–1440 (2006).
Corcoran, R.B. et al. Cancer Res. 71, 5020–5029 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Worchel, H., Magnuson, M. Cytokine-driven beta-cell production in vivo. Nat Biotechnol 32, 63–64 (2014). https://doi.org/10.1038/nbt.2788
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2788
- Springer Nature America, Inc.